| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/21/1993 | US5247070 N-terminal muteins of tumor necrosis factor |
| 09/16/1993 | WO1993018185A1 Receptor internalization signals |
| 09/16/1993 | WO1993018163A2 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | WO1993018054A2 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | CA2131995A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | CA2130100A1 Receptor internalization signals |
| 09/15/1993 | EP0559770A1 Cell stress transcriptional factors |
| 09/15/1993 | EP0276278B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 09/14/1993 | US5244793 TGF-β1/β2: a novel chimeric transforming growth factor-beta |
| 09/14/1993 | CA1322157C Bifunctional proteins |
| 09/08/1993 | EP0559234A1 Monoclonal antibodies specific for an epitope in the B chain of platelet-derived growth factor and their use in affinity chromatography |
| 09/08/1993 | EP0558645A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 09/08/1993 | EP0307434B1 Altered antibodies |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/05/1993 | CA2090834A1 Analysis of host cell shut-offs |
| 09/02/1993 | WO1993017105A1 Altered antibodies, products and processes relating thereto |
| 09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
| 09/02/1993 | WO1993017038A1 Methods of treating diabetes |
| 09/02/1993 | WO1993017030A1 Immunological detection of organophosphates |
| 09/02/1993 | WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens |
| 09/02/1993 | WO1993016709A1 Therapeutic domains of von willebrand factor |
| 09/02/1993 | CA2130182A1 Methods of treating diabetes |
| 09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
| 09/01/1993 | EP0557663A1 Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin |
| 09/01/1993 | EP0557455A1 Recombinant feline coronavirus s proteins |
| 09/01/1993 | EP0557388A1 Diagnosis and treatment of multiple sclerosis |
| 09/01/1993 | EP0527954A4 Molecular recognition units |
| 08/31/1993 | CA1321765C Immunodiagnostic assays using chimeric antigens |
| 08/25/1993 | EP0556328A1 Bridging antibody fusion constructs |
| 08/25/1993 | EP0199801B1 Methods for protein binding enzyme complementation assays |
| 08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
| 08/19/1993 | WO1993016186A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
| 08/19/1993 | WO1993016185A2 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | WO1993015766A1 Desensitization to specific allergens |
| 08/19/1993 | DE4219696A1 Hybrid-dna, plasmide, oligohybridpeptid und impfstoff Hybrid dna, plasmids, and oligohybridpeptid vaccine |
| 08/19/1993 | CA2372813A1 Biosynthetic binding protein for cancer marker |
| 08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
| 08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555363A1 Identification of a suppressor of atherogenic apolipoprotein |
| 08/18/1993 | EP0555336A1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like. |
| 08/18/1993 | EP0555286A1 Cell growth inhibitors |
| 08/18/1993 | EP0555205A1 Dna encoding a growth factor specific for epithelial cells |
| 08/17/1993 | US5236829 Method of producing monokine induced by gamma interferon |
| 08/11/1993 | EP0554708A1 Thioether conjugates |
| 08/11/1993 | EP0554670A2 Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics |
| 08/11/1993 | EP0194276B1 Production of chimeric antibodies |
| 08/10/1993 | US5234834 Constructs for expression of monellin in plant cells |
| 08/05/1993 | WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 08/05/1993 | WO1993015216A1 Novel heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof |
| 08/05/1993 | WO1993015211A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides |
| 08/05/1993 | WO1993015210A1 Monomeric and dimeric antibody-fragment fusion proteins |
| 08/05/1993 | WO1993015201A1 Novel protein tyrosine kinases |
| 08/05/1993 | WO1993015200A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
| 08/05/1993 | WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/05/1993 | WO1993015196A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof |
| 08/05/1993 | WO1993015193A1 Mammalian expression systems for hcv proteins |
| 08/05/1993 | WO1993015107A1 Amino procollagen 1(i) peptides |
| 08/05/1993 | WO1993014776A1 Icam-related protein |
| 08/05/1993 | CA2128877A1 Amino procollagen 1(1) peptides |
| 08/05/1993 | CA2128722A1 Novel protein tyrosine kinases |
| 08/05/1993 | CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor |
| 08/05/1993 | CA2128110A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof |
| 08/05/1993 | CA2126092A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
| 08/05/1993 | CA2125979A1 New polypeptides with a stimulating activity for granulocytes colonies; process for preparing the same and pharmaceutical compositions containing them |
| 08/05/1993 | CA2106382A1 Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof |
| 08/04/1993 | EP0553667A1 Soluble LDL receptor, its production and use |
| 08/04/1993 | EP0553244A1 Targeted immunostimulation with bispecific reagents |
| 08/04/1993 | EP0553113A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 08/04/1993 | EP0198026B1 Monoclonal antibodies to cyclosporings |
| 07/28/1993 | EP0552850A1 Cloning and expression of HTLV-III DNA |
| 07/28/1993 | CN1074684A Thioether conjugates |
| 07/28/1993 | CA2107097A1 Icam-related protein |
| 07/27/1993 | US5231001 Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 07/22/1993 | WO1993014207A1 Chimeric immunogens |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993010239A3 Hepatitis-c virus testing |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0551438A1 Surface expression libraries of randomized peptides |
| 07/20/1993 | US5229272 Catalytic antibody components |
| 07/20/1993 | CA1320350C Combination lock for blood identification system |
| 07/14/1993 | EP0550645A1 Surface expression libraries of heteromeric receptors |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/13/1993 | CA1320160C Monoclonal antibodies against ifn-omega, processes for preparing them and their use in the purification and detection of ifn-omega |
| 07/08/1993 | WO1993013421A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | WO1993013211A1 Expression and purification of recombinant soluble tissue factor |
| 07/08/1993 | WO1993013210A1 Icams immunoglobulin constant region soluble fusion proteins |
| 07/08/1993 | CA2126209A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/07/1993 | EP0550400A2 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 07/06/1993 | US5225331 Immunoassay for detecting group b streptococcus |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | CN1073719A Nanbv diagnostics and vaccines |
| 06/29/1993 | US5223441 Receptors for immune complexes |
| 06/29/1993 | US5223254 Polypeptide |
| 06/29/1993 | CA1319629C Fusion proteins |
| 06/29/1993 | CA1319628C Fusion proteins |
| 06/24/1993 | WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |